Craniometaphyseal Dysplasia

National Organization for Rare Disorders, Inc.

Skip to the navigation


It is possible that the main title of the report Craniometaphyseal Dysplasia is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.


  • Osteochondroplasia
  • CMD
  • Jackson type CMD

Disorder Subdivisions

  • None

General Discussion

Craniometaphyseal dysplasia is an extremely rare genetic disorder characterized by distinctive abnormalities of the head and facial (craniofacial) area, impairment of certain nerves (cranial nerves) that emerge from the brain, and malformations of the long bones of the arms and legs. In infants and children with craniometaphyseal dysplasia, there may be overgrowth and/or abnormal hardening of certain bones of the skull (cranial hyperostosis and/or sclerosis) and overgrowth (hypertrophy) of craniofacial bones, resulting in widely-spaced eyes (ocular hypetelorism), an abnormally wide nasal bridge, an enlarged lower jaw (mandible), and a "leonine" facial appearance (leontiasis ossea). Compression of certain nerves emerging from the brain (cranial nerves) may result in loss of some motor function (paralysis) in the facial area (cranial nerve palsy) and hearing loss (conductive and/or sensorineural hearing impairment). In addition, in individuals with the disorder, the long bones of the arms and legs may develop abnormally, resulting in unusual "club-like" flaring or broadening of the end portions (metaphyses) of the bones (metaphyseal dysplasia). In some cases, craniometaphyseal dysplasia may be inherited as an autosomal dominant genetic trait; in other cases, the disorder may have an autosomal recessive mode of inheritance.


Craniometaphyseal dysplasia is a genetic disorder that is usually evident at birth. This disorder is characterized by the abnormal growth (hyperostosis) or hardening of the bones of the forehead and back of the head. The facial bones may show thickening, especially at the bridge area of the nose and lower jaw bone (mandible). The nasal passages may be abnormally narrow, and affected individuals may experience inflammation of the mucous membranes (rhinitis). The eyes are widely spaced and bulging (proptosis). If cranial pressure is not relieved there may be facial paralysis, deafness and loss of vision due to compression of the brain and cranial nerves. The limbs may be affected by a hardening (sclerosis) or broadening of the shaft of the long bones close to the growth center (metaphyseal splaying). Intelligence is usually normal.


Craniometaphyseal dysplasia may be inherited either as an autosomal dominant trait, in which case the mutant gene has been tracked to the short arm of chromosome 5 (5p15.2-p14.1), or it may be inherited as an autosomal recessive trait, in which case the mutant gene has been tracked to the long arm of chromosome 6 (6q21-q22). The recessive form is the more rare of the two, and tends to have a more severe impact on those affected. People with the dominant form have milder symptoms.

The gene on chromosome 5 controls the production of a protein involved in the transport of pyrophosphate into the bone matrix. The concentration of pyrophosphate in the bone matrix is key to regulating the mineralization of the bone. The gene located at chromosome 6q21-q22 deals with an entirely different process in the development of bone.

Chromosomes, which are present in the nucleus of human cells, carry the genetic information for each individual. Human body cells normally have 46 chromosomes. Pairs of human chromosomes are numbered from 1 through 22 and the sex chromosomes are designated X and Y. Males have one X and one Y chromosome and females have two X chromosomes. Each chromosome has a short arm designated "p" and a long arm designated "q". Chromosomes are further sub-divided into many bands that are numbered. For example, "chromosome 5p15.2-p14.1" refers to a region between bands 15.2 and 14.1 on the short arm of chromosome 5. In a like manner the term "chromosome 6q21-q22" refers to a region between bands 21 and 22 on the long arm of chromosome 6. The numbered bands specify the location of the thousands of genes that are present on each chromosome.

Genetic diseases are determined by the combination of genes for a particular trait that are on the chromosomes received from the father and the mother.

All individuals carry a few abnormal genes. Parents who are close relatives (consanguineous) have a higher chance than unrelated parents to both carry the same abnormal gene, which increases the risk to have children with a recessive genetic disorder.

Dominant genetic disorders occur when only a single copy of an abnormal gene is necessary for the appearance of the disease. The abnormal gene can be inherited from either parent, or can be the result of a new mutation (gene change) in the affected individual. The risk of passing the abnormal gene from affected parent to offspring is 50% for each pregnancy regardless of the sex of the resulting child.

Recessive genetic disorders occur when an individual inherits the same abnormal gene for the same trait from each parent. If an individual receives one normal gene and one gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms. The risk for two carrier parents to both pass the defective gene and, therefore, have an affected child is 25% with each pregnancy. The risk to have a child who is a carrier like the parents is 50% with each pregnancy. The chance for a child to receive normal genes from both parents and be genetically normal for that particular trait is 25%. The risk is the same for males and females.

Affected Populations

Craniometaphyseal dysplasia is a very rare disorder that affects males and females in equal numbers. Little is known about the incidence or prevalence of this disorder.

Standard Therapies

Early surgical treatment of Craniometaphyseal Dysplasia to relieve cranial pressure and correct the facial deformities may help eliminate the sight and hearing complications associated with this disorder. Genetic counseling may be of benefit for patients and their families. Other treatment is symptomatic and supportive.

Investigational Therapies

Information on current clinical trials is posted on the Internet at All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.

For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:

Tollfree: (800) 411-1222

TTY: (866) 411-1010


For information about clinical trials sponsored by private sources, contact:



Reichenberger E, Mulliken JB. Craniometaphyseal Dysplasia. In: NORD Guide to Rare Disorders. Lippincott Williams & Wilkins. Philadelphia, PA. 2003:184.

Gorlin RJ, Cohen MMJr, Levin LS. eds. Syndromes of the Head and Neck. 3rd ed. Oxford University Press, London, UK; 1990:229.

Jones KL., ed. Smith's Recognizable Patterns of Human Malformation. 5th ed. W. B. Saunders Co., Philadelphia, PA; 1997:395.


Puri P, Chan J. Craniometaphyseal dysplasia: ophthalmic features and management. J Pediatr Ophthalmol Strabismus. 2003;40:228-31.

Sheppard WM, Shprintzen RJ, Tatum SA, et al. Craniometaphyseal dysplasia: a case report and review of medical and surgical management. Int J Pediatr Otorhinolaryngol. 2003;67:687-93.

Reichenberger E, Tiziani V, Watanabe S, et al. Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane transport protein ANK. Am J Hum Genet. 2001;68:1321-26.

Iughetti P, Alonso LG, Wilcox W, et al. Mapping of the autosomal recessive (AR) craniometa-physeal dysplasia locus to chromosome region ^q21-22 and confirmation of genetic heterogeneity for mild AR spondylocostal dysplasia. Am J Med Genet. 2000;95:482-91.

Feingold M. 28-year follow-up of the craniofacial findings in a patient with craniometaphyseal dysplasia. Am J Med Genet. 1999;86:501-02.

Tinschert S, Braun HS. Craniometaphyseal dysplasia in six generations of a German kindred. Am J Med Genet. 1998;77:175-81.


McKusick VA, ed. Online Mendelian Inheritance In Man (OMIM). The Johns Hopkins University. Craniometaphyseal Dysplasia, Autosomal Dominant; CMDD. Entry Number; 123000: Last Edit Date; 7/2/2001.

McKusick VA, ed. Online Mendelian Inheritance In Man (OMIM). The Johns Hopkins University. Craniometaphyseal Dysplasia, Autosomal Recessive; CMDR. Entry Number; 218400: Last Edit Date; 3/18/2004.

Skeletal Dysplasias. Orthoteers. Updated on: 27 January 2001. 5pp.

The Osteopetroses (Marble Bones). The Merck Manual. 2004.

Craniometaphyseal dysplasia. Encyclopedia of Medical Imaging III:1. Amersham Health. nd. 1p.


Children's Craniofacial Association

13140 Coit Road

Suite 517

Dallas, TX 75240


Tel: (214)570-9099

Fax: (214)570-8811

Tel: (800)535-3643



FACES: The National Craniofacial Association

PO Box 11082

Chattanooga, TN 37401

Tel: (423)266-1632

Fax: (423)267-3124

Tel: (800)332-2373




PO Box 751112

Las Vegas, NV 89136


Tel: (702)769-9264

Fax: (702)341-5351

Tel: (888)486-1209




333 East 30th Street, Lobby Unit

New York, NY 10016

Tel: (212)263-6656

Fax: (212)263-7534



Genetic and Rare Diseases (GARD) Information Center

PO Box 8126

Gaithersburg, MD 20898-8126

Tel: (301)251-4925

Fax: (301)251-4911

Tel: (888)205-2311

TDD: (888)205-3223


For a Complete Report

This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see